A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: The ECLIPSE (Epanova® compared to Lovaza® in a pharmacokinetic single-dose evaluation) study
Michael H. Davidson, Judith Johnson, Michael W. Rooney, Michael L. Kyle, Douglas F. KlingТом:
6
Рік:
2012
Мова:
english
DOI:
10.1016/j.jacl.2012.01.002
Файл:
PDF, 856 KB
english, 2012
File converter
Більше результатів пошуку
More benefits 
